Journal ArticleOPEN ACCESS

Germline TP53 c.566C>T mutation incidentally diagnosed during treatment for acute myeloid leukemia: A case report

Clinical Case Reports (2021) 9(12)
DOI: 10.1002/ccr3.5221
2Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

TP53 mutations in acute myeloid leukemia (AML) are associated with poor outcomes. The number of somatic and/or germline genetic tests for therapy is increasing. Patients with such incidental findings should undergo adequate genetic counseling.

Cite

CITATION STYLE

APA

Sato, H., Matsuo, S., Ando, Y., Imamura, Y., & Hirose, M. (2021). Germline TP53 c.566C>T mutation incidentally diagnosed during treatment for acute myeloid leukemia: A case report. Clinical Case Reports, 9(12). https://doi.org/10.1002/ccr3.5221

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free